Managing patients with cardiorenal metabolic disease
You must score at least 70% in this module to pass. Ensure you have read ‘Managing patients with cardiorenal metabolic disease’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
Quiz Summary
0 of 15 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 15 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 15
1. Question
What does cardiorenal metabolic disease (CRMD) refer to?
CorrectIncorrect - Question 2 of 15
2. Question
Why is early identification of CRMD important?
CorrectIncorrect - Question 3 of 15
3. Question
What is the biggest risk factor for both chronic kidney disease and (CKD) and cardiovascular disease (CVD)?
CorrectIncorrect - Question 4 of 15
4. Question
Which risk prediction tool estimates the likelihood of CVD events over a ten-year period?
CorrectIncorrect - Question 5 of 15
5. Question
What renal marker is a key predictor for CKD and CRMD progression?
CorrectIncorrect - Question 6 of 15
6. Question
How can you optimise a patient who has stage 3a diabetic kidney disease with HFrEF?
CorrectIncorrect - Question 7 of 15
7. Question
Why are SGLT2 inhibitors considered beneficial for CRMD?
CorrectIncorrect - Question 8 of 15
8. Question
Which is the statin of choice for primary prevention of cardiovascular disease?
CorrectIncorrect - Question 9 of 15
9. Question
What is the role of ACE inhibitors and ARBs in managing heart failure with chronic kidney disease?
CorrectIncorrect - Question 10 of 15
10. Question
What is the recommended use of statins in patients with chronic kidney disease and diabetes?
CorrectIncorrect - Question 11 of 15
11. Question
In which patient population is finerenone currently licensed for use in the treatment of chronic kidney disease?CorrectIncorrect - Question 12 of 15
12. Question
Which regimen is suitable to be given together?
CorrectIncorrect - Question 13 of 15
13. Question
Which of the following is a known side effect of SGLT2 inhibitors?
CorrectIncorrect - Question 14 of 15
14. Question
Which of the following medications should patients with chronic kidney disease temporarily stop during illness (vomiting, diarrhoea, fever) to reduce the risk of acute kidney injury?
CorrectIncorrect - Question 15 of 15
15. Question
Which of the following are modifiable lifestyle measures that you can counsel/signpost a patient towards. More than one answer may be correct
CorrectIncorrect